DCF — SWEDISH MEDICAL CENTER CHERRY HILL
Enterprise Value: $-1.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.1B
Enterprise Value
$-328.8M
PV of Cash Flows
$-730.2M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $477.3M | $-69.4M | -15.0% | $-89.6M | $-81.4M |
| Year 2 | $491.6M | $-66.5M | -14.0% | $-87.4M | $-72.2M |
| Year 3 | $506.3M | $-63.5M | -13.0% | $-84.9M | $-63.8M |
| Year 4 | $521.5M | $-62.8M | -12.0% | $-84.8M | $-58.0M |
| Year 5 | $537.2M | $-63.3M | -12.0% | $-86.1M | $-53.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$463.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15036568278097073
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5